OSI Pharmaceuticals is committed to shaping medicine and changing lives by discovering, developing and commercializing high quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer and diabetes/obesity.
Requests for grants, sponsorships and charitable donations may be made through (OSI) Oncology. Requests must be compliant with all applicable federal and state laws, the PhRMA Code and OSI Pharmaceuticals, Inc. policies and guidelines. OSI may publicly disclose the amount, recipient(s) and/or description of the grant/sponsorship
(OSI) Oncology, a business area of OSI Pharmaceuticals, Inc., is dedicated and committed to the discovery, development and commercialization of molecular targeted therapies (MTTs) to revolutionize the way cancer is treated and improve treatment outcomes.
(OSI) Oncology funding will be considered for certain organizations, including those listed below:
(OSI) Oncology will consider funding for certain activities including those listed below:
(OSI) Oncology funding will not be considered for certain purposes, including those listed below:
For reservations of exhibit space at meetings, please contact your local OSI representative or salesops@osip.com.
For grants to support clinical studies or other research, please contact Medical Information.
If you believe you qualify to apply for (OSI) Oncology funding, please click here.